Morningstar

NYLI MacKay Convertible Class I MCNVX

Morningstar Medalist Rating
Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 19.51  /  +0.46 %
  • Total Assets 1.6 Bil
  • Adj. Expense Ratio
    0.620%
  • Expense Ratio 0.620%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Convertibles
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 4.10%
  • Turnover 33%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0

Morningstar’s Analysis MCNVX

Will MCNVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable MCNVX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the MCNVX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of MCNVX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Still a solid choice.

Analyst Chiayi Tsui

Chiayi Tsui

Analyst

Summary

MainStay MacKay Convertible Bond’s selective mindset and steadfast investing style allow it to weather rough patches without major bruises, and a sensible, valuation-driven approach results in resilient performance.

by Chiayi Tsui
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MCNVX

More MCNVX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 20.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

NYLI U.S. Government Liquidity Class I

3.26 50.9 Mil
Cash and Equivalents

Lantheus Holdings Inc 2.625%

2.32 36.3 Mil
Corporate

TransMedics Group Inc. 1.5%

2.29 35.8 Mil
Corporate

Tetra Tech Inc 2.25%

2.25 35.2 Mil
Corporate

Microchip Technology Incorporated 0.125%

2.14 33.5 Mil
Corporate

Merit Medical Systems Inc. 3%

1.92 30.0 Mil
Corporate

NRG Energy, Inc. 2.75%

1.87 29.2 Mil
Corporate

Exact Sciences Corporation 1.75%

1.86 29.1 Mil
Corporate

Biomarin Pharmaceutical Inc. 1.25%

1.85 28.9 Mil
Corporate

Post Holdings Inc. 2.5%

1.81 28.4 Mil
Corporate

Sponsor Center